Background Worldwide data for cancer survival are scarce. We aimed to initiate worldwide
surveillance of cancer survival by central analysis of population-based registry data, as a …

Background In 2015, the second cycle of the CONCORD programme established global
surveillance of cancer survival as a metric of the effectiveness of health systems and to …

Background Cancer survival varies widely between countries. The CONCORD study
provides survival estimates for 1· 9 million adults (aged 15–99 years) diagnosed with a first …

Summary Background From 2003 to 2005, standardised 5-year cancer survival in China
was much lower than in developed countries and varied substantially by geographical area …

Background Population-based cancer survival estimates provide valuable insights into the
effectiveness of cancer services and can reflect the prospects of cure. As part of the second …

Background Cancer survival is a key measure of the effectiveness of health-care systems.
Persistent regional and international differences in survival represent many avoidable …

Millions of people will continue to be diagnosed with cancer every year for the foreseeable
future. These patients all need access to optimum health care. Population-based cancer …

Background Population-based cancer survival data, a key indicator for monitoring progress
against cancer, are not widely available from countries in Africa, Asia, and Central America …

Background Assessment of progress in cancer control at the population level is increasingly
important. Population-based survival trends provide a key insight into the overall …

Background Traditional cancer-survival analyses provide data on cancer management at
the beginning of a study period, and are often not relevant to current practice because they …